Objective: The aim of this study was to establish a predictive nomogram for predicting prostate cancer (PCa) in patients with gray-zone prostate-specific antigen (PSA) levels (4–10.0 ng/mL) based on radiomics and other traditional clinical parameters. This evidence concerns the gene KLK3 and prostate cancer.